Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
(S)-Bexicaserin
Cat. No.:
OB0125LY-039
Appearance:
Solid
Purity:
99.93%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
(S)-Bexicaserin is a selective 5-HT2B receptor antagonist.
Synonyms:
2035818-21-2; Bexicaserin; S-Bexicaserin
CAS No.:
2035818-21-2
Formula:
C15H19F2N3O
Formula Weight:
295.33
Specification
Target:
5-HT Receptor
Pathway:
GPCR/G Protein; Neuronal signaling
Storage:
Storage at 4°C.
Applications:
(S)-Bexicaserin has potential applications in the study of obesity and cardiovascular disease.
